Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) Revenue: 2020-2022

Historic Revenue for Therapeutics (RAPT) over the last 2 years, with Jun 2022 value amounting to $886,000.

  • Therapeutics' Revenue rose 1.96% to $886,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $3.2 million, marking a year-over-year decrease of 33.98%. This contributed to the annual value of $1.5 million for FY2022, which is 59.95% down from last year.
  • As of Q2 2022, Therapeutics' Revenue stood at $886,000, which was up 38.22% from $641,000 recorded in Q1 2022.
  • Therapeutics' 5-year Revenue high stood at $1.5 million for Q3 2020, and its period low was $641,000 during Q1 2022.
  • Over the past 3 years, Therapeutics' median Revenue value was $950,500 (recorded in 2020), while the average stood at $1.0 million.
  • In the last 5 years, Therapeutics' Revenue skyrocketed by 30.70% in 2021 and then tumbled by 47.55% in 2022.
  • Over the past 3 years, Therapeutics' Revenue (Quarterly) stood at $1.3 million in 2020, then tumbled by 41.94% to $756,000 in 2021, then increased by 1.96% to $886,000 in 2022.
  • Its Revenue stands at $886,000 for Q2 2022, versus $641,000 for Q1 2022 and $756,000 for Q4 2021.